The purpose of this editorial is to briefly discuss the problems which arise with the assessment of the carcinogenic potential of chemical substances in chronic (2 years or lifetime) toxicity studies. At the age of 2 years and beyond, a variety of neoplasms occur spontaneously in various organs of rodents in a random distribution among experimental and control groups. A higher tumor incidence in control rats over those exposed to a test compound is easily discarded as a chance incidence. However, the opposite usually creates severe problems of interpretation. Statistical analysis in these cases is often equivocal at best, and sometimes meaningless in assessing the carcinogenic potential of the test substance. It is, therefore, advisable fo precede statistical evaluation with a careful biologic analysis permitting distinction between spontaneous and induced tumor incidences. While this distinction may not be completely achievable in every case, separation in most instances with a high degree of certainty is possible.
Biologic criteria for such an evaluation should include: 1) capability to reliably and consistently increase the tumor incidence beyond the expected control level: 2) shift of the appearance of tumors to a younger age; 3) demonstration of a dose-effect relationship: 4) shift to more anaplastic tumor types; 5) appearance of unusual tumors; 6) presence of preneoplastic lesions; 7) high incidence of neoplasia in one organ or tissue (organ or cell specificity). Depending upon the experimental design, the carcinogenic potential of the test substance, and the availability of tissue samples at various stages during the course of the experiment not all of these criteria may apply to or be testable in every singIe case. Some, however, will always be present and permit distinction of experimentally induced tumors from naturally occurring neoplasms.
Although most of these criteria need no further explanation, the first should be expanded upon. It is phrased in a way to permit usage of historic controls in addition to the matched control. This is important because of the random distribution of tumors among the various groups of animals in any experimental setting. Equal distribution of spontaneous tumors among groups of animals is rare and the chances are always greater for one of several experimental groups to be randomly affected by a high incidence of tumors than they are for the single control group. The results become alarming if the highest tumor incidence coincides with the highest dose group and the lowest incidence with the control group. Historic control data for the tumor type in question, if available, will then provide valuable information on the expected incidences of various neoplasms as they pertain to particular species, strain, sex, and age of animal. If, for example, reliable historic controls report a spontaneous incidence range of 2.5-3.3% gliomas in 2-year-old male Charles River CD rats and the tumor incidence in the experiment falls within that range, there is not much of a case regardless of distribution, particularly if none of the other biologic criteria have been fulfilled.
The most valuable historic control data are provided by the so-called "pooled laboratory controls." In such a case all data have been derived from the same laboratory and strain, age, sex, housing. management, and methods of examination are comparable to the experiment in question. Often, the same pathologist performed the gross and histologic examination in all studies. In addition, reliable historic control data are now available through the literature for the most commonly used rodent strains and provide useful information for both survival curves and tumor incidences.
The remaining criteria listed above are selfexplanatory, and other criteria may be added as they apply to specific tumors. The value of their application differs with the tumor type and incidence, but these criteria must be an integral part of carcinogenicity testing. It is, in my opinion, inexcusable to subject raw data to a statistical analysis before a thorough pathobiologic examination has been performed and the carcinogenic potential of a substance has been biologically established. As in all areas of biology, we must expect to deal with a wide spectrum of biologic variations. Meticulous analysis of consistently detectable characteristics of experimentally induced neoplasms, as compared to spontaneous tumors, is the only way to reduce existing uncertainties and establish sharper borderlines between the two.
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